ADHD CME

Improving Executive Function in Adult ADHD

Overview

This 30 minute presentation with Lenard Adler, MD clarifies how the primary care practitioner can identify Executive Function Deficits in ADHD patients which are separate from symptoms of ADHD. Both the symptoms and deficits can be ameliorated with effective and very different kinds of therapy. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, you will be able to:

• Identify potential Executive Function Deficits in patients
• Know what symptom relief to look for in using stimulant and non-stimulant medications for ADHD patients with Executive Function Deficits
• Refer ADHD patients with Executive Function Deficits out to appropriate types of therapy

Presented by

Lenard A. Adler, MD

Professor of Psyciatry and 
Child and Adolescent Psychiatry
Directory of the Adult ADHD Program
NYU School of Medicine
New York, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

ADHD CME

Clinical Correlates of Working Memory Deficits in ADHD

Overview

In this one-hour presentation, Joseph Biederman, MD describes they symptoms of working memory deficits as a set of Executive Function Deficits (EFDs) that can accompany ADHD and in fact have similar neural correlates in the brain. Dr. Biederman describes these phenomena throughout the lifespan, with research data in children, young adults, and adults. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

• Describe working memory deficits and distinguish them from ADHD symptoms
• Identify working memory deficits in patients based on your new understanding of prevalence
• Successfully refer ADHD patients with suspected working memory deficits to outside professional for assessment
• Teach your patients and their families about working memory deficits in association with ADHD and raise their awareness and consideration of options

Presented by

Joseph L. Biederman, MD

Chief of the Clinical and Research Programs in
Pediatric Psychopharmacology and Adult ADHD
Massachusetts General Hospital

Professor of Psychiatry
Harvard Medical School
Boston, Massachusetts

Course Runs: Sept 1, 2020 – Sept 1, 2021

ADHD CME

ADHD and Substance Use Disorder

Overview

In this 66-minute presentation, Anthony Rostain, MD, MA clearly describes the neural correlates that ADHD patients share with proclivity toward substance abuse. He reviews the risks of Substance Use Disorder (SUD) in teenagers, college students, and adults, discusses appropriate medication usage, and describes multiple treatment approaches (both pharmaceutical and cognitive therapies) that clinicians can use to treat both ADHD and SUD. A trusting clinician-patient relationship is an important key to treatment success. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to describe:

• The prevalence, phenomenology and impact of Substance Use Disorders in youth and adults with ADHD
• Current theories regarding the links between ADHD and SUD
• Key studies documenting the occurrence of stimulant misuse and abuse among college and university students
• Clinical strategies for managing ADHD in the presence of SUD and for reducing the misuse/abuse of stimulant medications in at-risk patients

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania and Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021

ADHD CME

More than the sum of its parts:
Comorbid and Reverse Comorbid Bipolar Disorder and ADHD

Overview

In this webcast, Dr. Nierenberg describes different major networks in the brain and their function; discusses diagnosis of dysregulations in ADHD and bipolar patients; identifies appropriate medications for ADHD and Bipolar Disorder; and explains the switching problems that patients may have among brain modes.

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

• Describe different major networks in the brain and their function
• Recognize and diagnose dysregulations in ADHD and bipolar patients 
• Prescribe appropriate medications for ADHD and Bipolar Disorder
• Explain to patients the switching problems they have among brain modes

Presented by

Andrew A. Nierenberg, MD

Thomas P. Hackett Endowed Chair in Psychiatry at MGH

Dauten Family Center for Bipolar Treatment Innovation
Massachusetts General Hospital

Professor of Psychiatry
Harvard Medical School

Course Runs: Sept 1, 2020 – Sept 1, 2021

ADHD CME

Assessing Functional Outcomes in Young Adults with ADHD

Overview

This 27-minute presentation with Lenard Adler, MD explains the components of a complete diagnosis and ADHD in adults and how to distinguish the symptoms of ADHD from frequently comorbid executive function deficits.

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

• Explain the components of a complete diagnosis of ADHD in adults
• Recognize the symptoms of ADHD and executive function impairment in your patients.
• Use the quality of life indicators to screen for ADHD in adults
• Be prompted to screen your patients for ADHD form comorbid disorders

Presented by

Lenard A. Adler, MD

Professor of Psychiatry and 
Child and Adolescent Psychiatry
Director of the Adult ADHD Program 
NYU School of Medicine 
New York, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

ADHD CME

Late Onset and Atypical Forms of Attention Deficit Hyperactivity Disorder

Overview

In this 50 minute presentation, Stephen V. Faraone, PhD presents atypical cases of ADHD which can confound diagnosis in the clinical setting. Clinical guidance is given in clarifying how to diagnose ADHD with late onset beyond the DSM-5 age of 12, as well as individuals with both low and high IQ who may also have ADHD. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

• Separate the symptoms of intellectual disability and low IQ from symptoms of ADHD, in order to make an ADHD diagnosis
• Identify significant impairments in high IQ that may lead to an ADHD diagnosis despite their intelligence
• Diagnose young adults with ADHD whose symptoms may have developed or become more severe at ages older than the DSM-5 criterion of age 12

Presented by

Stephen V. Faraone, PhD

Distinguished Professor
Departments of Psychiatry and 
Neuroscience and Physiology
SUNY Upstate Medical University

President, World Federation of ADHD

Course Runs: Sept 1, 2020 – Sept 1, 2021

ADHD CME

Pharmacological Treatment of Comorbid ADHD

Overview

This webcast was recorded live and is being used with the permission of the presenter.

In this 1-hour session, Joseph Biederman, MD discusses ADHD medications and how to handle psychiatric comorbidities such as:  depression, anxiety, phobia, OCD, Tourette’s, nictotine dependence, and alcoholism.

Only 20% of ADHD adults are diagnosed and treated.
So most of what clinicians will see in clinical care first are other mental and behavioral health disorders that accompany ADHD.

40% of ADHD patients have nicotine dependence.
30% of ADHD patients show alcohol abuse.
50% of ADHD patients have major depressive disorder.

50% of ADHD patients have anxiety disorder.

If you don’t know about or treat the underlying ADHD, standard medical protocols will not relieve the other disorders we’ve just mentioned.

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

• identify which adult adhd symptoms to treat first
• which combinations of adhd medications and cognitive behavioral therapy to use
• reduce the risk for these comorbidities by treating ADHD as early as possible in the patient’s life.
• distinguish what symptoms of ADHD can be reduced by medications, and which symptoms respond better to other treatments.

Presented by

Joseph L. Biederman, MD

Chief of the Clinical and Research Programs in 
Pediatric Psychopharmacology and Adult ADHD
Massachusetts General Hospital

Professor of Psychiatry
Harvard Medical School
Boston, Massachusetts

ADHD CME

Managing Medical Issues in Adult ADHD Treatment

Overview

In this one-hour session, Anthony L. Rostain, MD, MA reviews the numerous medical conditions which are most commonly present with adult ADHD and can in fact be triggers for diagnosing ADHD – smoking, eating disorders, substance abuse and others. Dr. Rostain reviews the list of ADHD medications and their appropriate use with comorbid conditions, as well as discussing ADHD and pregnancy, ADHD and lifestyle management, and side effects of ADHD medications. 

This webcast was recorded live and is being used with the permission of the presenter. 

After completing this activity, participants will be able to manage medical issues arising in the care of adults with ADHD, including:

• Choosing to screen for ADHD based upon known and existing patient medical conditions
• Selecting appropriate ADHD medications
• Monitoring and managing common medical side effects of stimulant medications
• Screening for cardiovascular conditions to increase medication safety
• Discussing with patients the management of health and well being 

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021